MP

Michael Parini

Chief Executive Officer

Freeline Therapeutics GmbH

New York, New York


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Freeline Therapeutics GmbH
Industry
research
Employees
330.0
Seniority
C suite

Technologies

Salesforce Outlook NetSuite MailChimp SPF Zendesk Barracuda Networks Amazon SES Varnish Gravity Forms WordPress.org Nginx Google Tag Manager Mobile Friendly Vimeo Google Maps Google Font API Render Remote AI Viewpoint Basis

Keywords

aav gene therapy life changing innovation purpose biotechnology gaucher parkinsons disease biotechnology: biological products (no diagnostic substances) health care biotechnology research clinical-stage biotech life-changing therapies transformational gene therapies gaucher disease parkinson's disease adrenomyeloneuropathy amn disease-modifying treatments chronic conditions genetic medicines biotech gene expression aav capsids therapeutic proteins mutated genes rare diseases chronic disease treatment in vivo therapy ex vivo therapy preclinical studies clinical trials therapeutic benefit protein production envelope-free viral vectors safety & efficacy fda compliance genetic material delivery personalized medicine regulatory approval one-time gene therapy infusion chronic condition management biopharma industry genetic medicine innovation healthcare collaboration affordable treatments transgene optimization immunogenicity reduction disease progression intervention transformative outcomes gene therapy pipeline leading chronic illness therapies therapeutic advancements clinical results optimization disease-targeting strategies treatment burden reduction genetic therapy education patient well-being improvement dementia cardiovascular diseases clinical-stage biotechnology innovative medicine genetic medicine transformative therapies neurological disorders patient-centric fda approval market potential healthcare professionals patient outcomes unmet medical needs genetic disorders therapeutic innovation pipeline development collaborative approach breakthrough treatments one-time therapies disease-modifying therapies chronic debilitating conditions optimized gene therapy patient engagement biotechnology partnerships health technology clinical research genetic engineering health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans